Group 1: Company Overview and Production Capacity - The company has two production bases located in Kunming and Fangchenggang, with a total designed capacity for various phosphate products [2][3] - Kunming base's designed capacities include: 100,000 tons/year of dicalcium phosphate, 150,000 tons/year of calcium hydrogen phosphate, 150,000 tons/year of calcium phosphate type III, 150,000 tons/year of heavy (rich) calcium, and 10,000 tons/year of sodium fluorosilicate [2] - Fangchenggang base's designed capacities include: 140,000 tons/year of heavy (rich) calcium, 150,000 tons/year of industrial wet-process phosphoric acid (after technical transformation), and 15,000 tons/year of sodium fluorosilicate [2] Group 2: Financial Performance and Forecast - The company reported a year-on-year performance increase for the first three quarters of 2025, attributed to strong market demand and flexible production adjustments [3] - The company plans to gradually increase the dividend payout ratio, responding to actual performance and national policy [3] - The projected annual revenue from the Egypt project upon reaching full capacity is expected to exceed 2 billion yuan, with a net profit exceeding 300 million yuan and an internal rate of return of 22.30% [4] Group 3: Future Projects and Investments - The Egypt project has a construction scale of 800,000 tons of sulfuric acid production, 300,000 tons of industrial wet-process crude phosphoric acid, and other products, with a total investment of 1.933861 billion yuan [4] - The construction period for the Egypt project is estimated to be 3 years, with an expected production start date in July 2028 [4] - The strategic significance of the Egypt project includes establishing an overseas processing center, optimizing cost structure, and enhancing market competitiveness and profitability [4] Group 4: Resource Security Measures - The Kunming base sources phosphate mainly from surrounding areas, utilizing low-grade phosphate ore to produce high-quality phosphate concentrate, which offers a price advantage [4] - The Fangchenggang base sources phosphate from overseas and northern China, leveraging port advantages for optimal procurement based on domestic and international price fluctuations [4]

据公告，此次收购的主要目的是为了提升公司在磷酸钙盐饲料添加剂行业的市场竞争力。 据悉，这笔交易涉及的股权包括了周荣超、周吕差等多方股东持有的股份，交易完成后，南漳龙蟒将间接持有天宝公司60%的股份，从而将其纳入 公司的合并报表范围。 星标 ★ IPO日报 精彩文章第一时间推送 随着化工行业整合的加速，未来的市场竞争将愈发激烈，这家公司能否成功转型，抢占更多市场份额？ 近期，磷化工行业的领军企业川发龙蟒宣布，其全资子公司南漳龙蟒磷制品有限责任公司（下称"南漳龙蟒"）拟以4.32亿元收购天宝动物营养科技 股份有限公司（下称"天宝公司"）60%的股份。 制图：佘诗婕 01 大转弯 川发龙蟒创立于1997年，于2009年在深交所挂牌上市。公司注册资本雄厚，达到18.91亿元，其控股股东为四川发展（控股）有限责任公司全资子公 司——四川省先进材料产业投资集团有限公司，实际控制人是四川省政府国有资产监督管理委员会。 据悉，目前，公司的主营业务集中在磷化工领域，产品线丰富，包括工业级磷酸一铵、肥料级磷酸一铵、饲料级磷酸氢钙、肥料级磷酸氢钙、高浓 度复合肥以及中低溶度复合肥等。 其中，"蟒牌"作为公司的核心品牌，已成功跻身中 ...